期刊文献+

术前放化疗与单纯手术治疗食管鳞癌的随机对照研究 被引量:11

Randomized controlled study on preoperative concurrent chemoradiotherapy versus surgery alone for esophageal squamous cell carcinoma
在线阅读 下载PDF
导出
摘要 目的:评价食管癌术前同期放化疗的有效性和安全性,以及对提高生存率的价值。方法:对术前临床分期为ⅡB、Ⅲ期,无外科手术和放化疗禁忌证的80例食管癌患者进行随机分组:综合治疗组和对照组各40例。综合治疗组,40例患者术前采用新辅助放化疗(5-氟尿嘧啶+顺铂)2个周期,同期进行放疗,直线加速器放射治疗(剂量40Gy),放化疗结束后3~5周手术切除;对照组则采用单纯手术治疗。采用SPSS11.10软件进行χ2检验和生存率分析。结果:综合治疗组和对照组的根治性切除率分别为97.5%和90%;综合治疗组TNM分期比对照组明显降低;术后并发症2组发生率无明显差异,综合治疗组生存率明显优于对照组。结论:术前辅助性放化疗能显著提高食管癌根治性切除率,提高生存率,降低TNM分期和区域淋巴结转移,减少局部复发和远处转移。 Objective:This study was performed to assess the efficacy and safety of preoperative concurrent chemotherapy and radiotherapy for esophageal cancer and its value in improving survival rate. Methods: Eighty patients at Ⅱ B and Ⅲ clinical stages and without contraindications for surgery and radiochemotherapy were selected in the study. They were randomly assigned into two groups with 40 patients in each group. Patients in combined therapy group were given two cycles of neoadjuvant chemotherapy ( 5-fluorouracil 500 mg/m^2 + cisplatin 75 mg/m^2 ) and the concurrent radiotherapy. Linear accelerator machine produced radiation at the dosage of 40 Gy. The tumor was resected at 3-5 weeks after concurrent chemotherapy and radiotherapy. Patients in the control group received surgery alone. SPSS software was used to performx2 test and make survival rate analysis. Results: The radical resection rates were 97.5% and 90% in the combined therapy group and control group, respectively. TNM staging was significantly decreased in the combined therapy group than that in the control group; there was no significant difference in the incidence of postoperative complications between the two groups. The postoperative survival rate of the combined therapy group was significantly higher than that of the control group. Conclusion: Preoperative adjuvant chemoradiotherapy markedly increased the radical resection rate and survival rate, decreased the TNM staging and regional lymph node metastasis, and suppressed local recurrence and distal metastasis.
出处 《肿瘤》 CAS CSCD 北大核心 2008年第7期620-622,共3页 Tumor
关键词 食管肿瘤 抗肿瘤联合化疗方案 外科手术 Esophageal neoplasms Antineoplastic combined chemotherapy protocols Surgical procedures
  • 相关文献

参考文献9

  • 1McDONNELL C O, BOUCHIER-HAYES D J, TOOMEY D, et al. Effect of neoadjuvant chemoradiotherapy on angiogenesis in oesophageal cancer[J]. Br J Surg,2003,90( 11 ) :1373-1378.
  • 2ILSON D H, MINSKY B. Irinoteean in esophageal cancer [ J ]. Oncology (Williston Park) ,2003 ,17(9 Suppl 8) :32-36.
  • 3KELLEY S T, COPPOLA D, KARL R C. Neoadjuvant chemoradiotherapy is not associated with a higher complication rate vs surgery alone in patients undergoing esophagectomy [ J ]. J Gastrointest Surg,2004 ,8( 3 ) :227-231.
  • 4MAKARY M A, KIERNAN P D, SHERIDAN M J, et al. Multimodality treatment for esophageal cancer: the role of surgery and neoadjuvant therapy [ J ]. Am Surg, 2003,69 ( 8 ) : 693-700.
  • 5BURMEISTER B H, SMITHERS B M, GEBSKI V, et al. Surgery alone versus chemoradiotherapy followed by surgery for resectable cancer of the oesophagus: a randomised controlled phase Ⅲ trial [J]. Lancet Oncol,2005,6(9) :659-668.
  • 6YAMASHITA H,NAKAGAWA K, TAGO M, et al. Treatment resuits of preoperative concurrent chemoradiotherapy followed by surgery for stage Ⅲ or Ⅳ esophageal squamous cell carcinoma[J]. Radiat Med,2006,24( 1 ) :65-71.
  • 7傅剑华 戎铁华 李小东 等.术前放化疗并手术治疗局部晚期食管癌的Ⅱ期临床研究[J].癌症,2003,23(11):1473-1476.
  • 8VAN MEERTEN E, MULLER K, TILANUS H W, et al. Neoadjuvant concurrent ehemoradiation with weekly paelitaxel and earboplatin for patients with oesophageal cancer: a phase 11 study [J]. Br J Cancer,2006,94(10 ) :1389-1394.
  • 9MALAISRIE SC, HOFSTETTER WL, CORREA AM,et al. The addition of induction chemotherapy to preoperative, concurrent chemoradiotherapy improves tumor response in patients with esophageal adenocareinoma [ J ]. Cancer, 2006, 107 ( 5 ) : 967- 974.

共引文献2

同被引文献70

引证文献11

二级引证文献71

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部